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Article Information  ABSTRACT 
Received: 15th March 2017  This presented work is based on application of two multivariate calibration methods for 
simultaneous UV-VIS spectrophotometric determination of active substances in combined 
pharmaceutical formulation composed of Atorvastatin calcium (ATV) and Ezetimibe (EZT). 
The methods used were Principal Component Regression (PCR) and Partial Least Square (PLS). 
The Spectra of ATV and EZT were recorded at concentrations within their linear range 5.0-30.0 
μg/ml for both drugs. 28 set of mixtures were used for calibration and 08 set of mixtures were 
used for validation in the wavelength range of 230 to 260 nm with the wavelength intervals λ= 
0.5 nm in methanol. The methods were validated as per International Conference on 
HarmonizationQ2 (R1) (ICH) guidelines. These methods were successfully applied for 
determination of drugs in pharmaceutical formulation (tablet) with no interference of the 
excipient as indicated by the recovery study results. The proposed methods are simple, rapid and 
can be easily used as an alternative analysis tool in the quality control as well as in process 
control of drugs and formulation. 
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INTRODUCTION 
Atorvastatin calcium is[R-(R, R*)]-2-(4-flurophenyl)-β,δ-
dihydroxy-5(1methylethyl)-3-phenyl-4- [phenylamino 
carbonyl]-1H-pyrrole-1-heptanoic acid, calcium salt [Fig. 1(a)] 
is well-known member of the drug class known as statins, 
which are used primarily as a lipid-lowering agent that inhibits 
HMG-CoA reductase enzyme which is found in liver tissue for 
production of cholesterol [1]. It is official in Indian 
Pharmacopeia [2]. Ezetimibe is 1-(-4-flurophenyl)-(3S)-
hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2azeti-dinone [Fig. 
1(b)] is a selective cholesterol absorption inhibitor, which 
potentially inhibits the absorption of biliary and dietary 
cholesterol[3]. It is official in Indian Pharmacopeia[4].Several 
methods are reported for quantitative determination of ATV 
and EZT in single and in combination such as UV, HPTLC, 
and RP-HPLC [5-14]. Chemometric is the science of extracting 
information from chemical systems. Multivariate calibration 
method (e.g., multiple linear regression (MLR), principle 
component regression (PCR) and partial least squares (PLS) 
utilizing spectrophotometric data are the important 
chemometric approach for determination of mixtures including 
drugs combination [15]. While working on development of 
simple, accurate and precise method for this combination we 
came across one recent report for analysis of these drugs by 
chemometric analysis using MATLAB software [16].We have 
developed method using Unscrambler X (10.3) software. 
Compared with reported method the results were found 
promising. 
 
MATERIALS AND METHODS 
Instrumentation 
Double beam UV- Vis spectrophotometer (Jasco V-730) with 
matched pair of 1cm quartz cells were used to record spectra of 
all solutions. The spectra were recorded at spectral band width 
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of 2.0 nm, scanning speed 100 nm/min and data pitch 0.5 nm. 
Unscrambler X (10.3) (64-bit) trial version and Microsoft 
Excel 2013 were used for model generation and application of 
chemometric. 
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Figure 1: Structure of a) Atorvastatin calcium (ATV) and b) 
Ezetimibe (EZT) 
 
Material and Reagents 
Reference standard of ATV and EZT were obtained from 
Wockhardt Research Centre, Aurangabad as gift samples and 
methanol (AR grade) purchased from LOBA Chemie, India. 
Atorsave EZ tablets manufactured by Eris Life Sciences Pvt. 
Ltd. containing Atorvastatin calcium IP 10 mg and Ezetimibe 
IP 10 mg were procured from local pharmacy shop. 
 
One component calibration 
To find linear concentration of each drug, one component 
calibration was performed. Linear dynamic ranges were studied 
in the concentration range of 5.0-30.0 μg/ml for both ATV and 
EZT. Absorbance values were recorded at λmax of each drug 
(247 nm for ATV and 233 nm for EZT) against methanol as 
blank. Linear dynamic range for each compound was 
determined by least-square linear regression of concentration 
and the corresponding absorbance. Fig. 2 represents Individual 
spectra, mixtures and sum of the spectra for ATV and EZT. 
According to the figures, there is no interaction between 
analytes as the signals appear with additive properties. 
 
Figure 2: Individual spectra, mixtures and sum of the spectra 
for ATV and EZT 
 
Preparation of standard stock solution 
Stock solution of ATV and EZT were prepared by dissolving 
accurately weighed 10 mg of standard drug in 10 ml of 
methanol, separately. The concentration of ATV and EZT were 
1000 μg/ml from which further 5 ml was pipetted and diluted to 
50 ml to achieve final concentration of 100 μg/ml of ATV and 
EZT, separately. 
 
Preparation of working stock solution 
Working standard solutions were prepared from standard stock 
solution of 100 μg/ml by appropriate dilution with methanol to 
obtain final concentration of 5, 10, 15, 20, 25 and 30 μg/ml for 
both ATV and EZT respectively. 
 
Construction of calibration and validation set 
A total set of 36 mixtures were prepared by combining working 
standard of ATV and EZT in their linear concentration range of 
5.0-30.0 μg/ml. (Table I). From these 28 mixtures were used 
for calibration set and 08 mixtures were used for validation set 
by random selection. The absorbance spectra were recorded in 
range of 230- 260 nm with 0.5 nm interval. The spectra were 
saved as ASCII (.txt) format which were further extracted in 
MS-Excel as required by Unscrambler software for model 
generation. The PCR and PLS models were developed utilizing 
absorption data using Unscrambler software. Selection of 
proper number of latent variables for development of model 
was necessary to obtain good prediction. Leave-one-out (LOO) 
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cross validation method was used to obtain necessary number 
of latent variables (LVs), as shown in Fig. 3 and calculated 
using formula [17], 
RMSECV = ∑
(𝑪𝒂𝒄𝒕−𝑪𝒑𝒓𝒆)𝟐
𝑰𝒄
 
Where, 
RMSECV= Root mean square error of cross validation 
Cact= actual concentration of calibration set 
Cpre= predicted concentration of validation set 
Ic= Total number of samples in calibration set 
 
Figure 3: Explained Variance describing number of optimum 
PCs (Principle Components) 
 
After the PCR and PLS models have been constructed, it was 
found that the optimum number of LVs were two factors for 
both PCR and PLS. For validation of generated models, 
concentration in validation set was predicted by using proposed 
PCR and PLS models (Table II). The validation of developed 
methods was performed as per ICH Q2 (R1) [18]. 
 
Assay of marketed preparation 
20 tablets of AtorsaveEZ were accurately weighed and finely 
powdered. Tablet powder equivalent to 10 mg of ATV (10 mg 
of EZT) was taken and transferred to 10 ml volumetric flask 
and was diluted to 10 ml with methanol. The solution was 
sonicated for 10 minutes. This solution was then filtered with 
help of whatman filter paper no. 41. 1 ml of filtrate solution 
was diluted to 10 ml with methanol. Further 1 ml of this 
solution was diluted to 10 ml with methanol to get final 
concentration of 10 μg/ml of ATV and EZT each. The 
procedure was repeated 6 times for tablet formulation.The 
assay results are presented in Table III. 
Accuracy study 
The accuracy study was carried out at three levels 50 %, 100 % 
and 150 % of assay concentration. Calculated amount of ATV 
and EZT from standard solutionswere spiked into sample 
solution and scanned in range of 230-260 nm. Concentrations 
were predicted by using developed PCR and PLS models. 
Accuracy data is presented in Table IV and Table V. 
 
Table I: Composition of calibration and validation sets. 
MIX. 
NO 
ATV 
 (μg/ml) 
EZT 
(μg/ml) 
MIX. 
NO 
ATV 
 (μg/ml) 
EZT 
(μg/ml) 
1 5 15 19 25 10 
2 5 20 20 25 15 
3 5 25 21 25 20 
4 5 30 22 25 25 
5 10 5 23 25 30 
6 10 10 24 30 5 
7 10 15 25 30 15 
8 10 20 26 30 20 
9 10 25 27 30 25 
10 10 30 28 30 30 
11 15 15 29 5 5 
12 15 20 30 5 10 
13 15 25 31 15 5 
14 20 5 32 15 10 
15 20 10 33 15 30 
16 20 15 34 20 20 
17 20 25 35 20 30 
18 25 5 36 30 10 
*Calibration set - Mix No. 1-28 
*Validation set - Mix No. 29-36 
 
Precision 
Precision was carried at three concentration levels (10, 15, 20 
μg/ml for both ATV and EZT) in three replicates at each level. 
The results of intraday and interday precision studies which are 
presented in Table VI and Table VII. 
 
LOD and LOQ 
LOD and LOQ were calculated as 3.3 σ/S and 10 σ/S, 
respectively; where σ is the standard deviation of the response 
(y-intercept) and S is the slope of the calibration plot. 
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Table II: Predicted results for validation set by PCR and PLS method.  
METHOD PCR PLS 
ATV EZT ATV EZT ATV EZT 
Actual (μg/ml) Predicted % R* Predicted % R* Predicted % R* Predicted % R* 
5 5 5.046 100.9 5.013 100.2 5.046 100.9 5.016 100.3 
5 10 5.070 101.4 10.129 101.2 5.077 101.5 10.122 101.2 
15 5 15.108 100.7 4.902 98.0 15.108 100.7 4.903 98.0 
15 10 15.560 103.7 9.882 98.8 15.559 103.7 9.884 98.8 
15 30 15.106 100.7 29.127 97.0 15.105 100.7 29.128 97.0 
20 20 19.942 99.7 21.488 107.4 19.946 99.7 21.484 107.4 
20 30 19.626 98.1 30.412 101.3 19.627 98.1 30.411 101.3 
30 10 29.965 99.8 9.895 98.9 29.966 99.8 9.894 98.9 
* % R - % Recovery 
 
Table III: Assay result for ATV and EZT in tablet (AtorsaveEZ) by proposed methods 
METHOD PCR PLS 
ATV EZT ATV EZT ATV EZT 
Actual 
(μg/ml) 
Predicted 
(μg/ml) 
% R 
Predicted 
(μg/ml) 
% R 
Predicted 
(μg/ml) 
% R 
Predicted 
(μg/ml) 
% R 
10 10 9.716 97.1 9.877 98.7 9.700 97.0 9.878 98.7 
10 10 9.969 99.6 9.922 99.2 9.968 99.6 9.927 99.2 
10 10 9.959 99.5 9.975 99.7 9.954 99.5 9.975 99.7 
10 10 10.004 100.0 10.162 101.6 10.001 100.0 10.164 101.6 
10 10 9.979 99.7 9.892 98.9 9.975 99.7 9.899 98.9 
10 10 9.995 99.9 9.916 99.1 9.994 99.9 9.917 99.1 
MEAN 9.937 99.3 9.957 99.5 9.932 99.3 9.960 99.6 
SD 0.109 1.095 0.105 1.057 0.114 1.148 0.105 1.050 
* % R - % Recovery 
 
Table IV: Accuracy data of ATV by PCR and PLS models. 
Level 
% 
Sample 
Conc. 
μg/ml 
Amount 
added 
μg/ml 
Total 
Conc. 
μg/ml 
Predicted Conc. 
μg/ml 
% Recovery % RSD 
 PCR PLS PCR PLS PCR PLS 
 
50 % 
 
10 5 15 
14.88 
14.97 
14.99 
14.88 
14.97 
14.69 
99.2 
99.8 
99.9 
99.2 
99.8 
97.9 
 
0.389 
 
0.953 
 
100 % 
 
10 10 20 
20.08 
20.15 
19.85 
20.07 
20.14 
19.85 
100.4 
100.7 
99.2 
100.3 
100.7 
99.2 
 
0.774 
 
0.773 
 
150 % 
 
10 15 25 
24.64 
25.37 
24.98 
  24.64 
25.37 
24.97 
98.5 
101.5 
99.9 
98.5 
101.5 
99.9 
 
1.466 
 
1.466 
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Table V: Accuracy data of EZT by PCR and PLS models. 
LEVEL 
% 
Sample 
Conc. 
μg/ml 
Amount 
added 
μg/ml 
Total 
Conc. 
μg/ml 
PREDICTED CONC. 
μg/ml 
% Recovery % RSD 
 PCR PLS PCR PLS PCR PLS 
 
50 % 
 
10 5 15 
14.912 
15.093 
14.939 
14.919 
15.080 
14.954 
99.4 
100.6 
99.5 
99.4 
100.5 
99.6 
 
0.651 
 
0.563 
 
 
100 % 
 
10 10 20 
20.285 
20.281 
20.088 
20.297 
20.292 
20.099 
101.4 
101.4 
100.4 
101.4 
101.4 
100.4 
 
0.557 
 
0.558 
 
150 % 
 
10 15 25 
24.824 
25.020 
24.843 
24.839 
25.035 
24.858 
99.2 
100.0 
99.3 
99.3 
100.1 
99.4 
 
0.433 
 
0.433 
 
Table VI: Precision results obtained using developed PCR and PLS models (Intraday Precision) 
Amount taken 
μg/ml 
Predicted Conc. μg/ml % Recovery % RSD 
 
ATV 
 
EZT 
PCR 
ATV         EZT 
PLS 
ATV          EZT 
PCR 
ATV          EZT 
PLS 
ATV          EZT 
PCR 
ATV      EZT 
PLS 
ATV      EZT 
10 
10 
10 
10 
10 
10 
9.99 
10.04 
10.27 
9.93 
10.23 
10.16 
9.99 
10.04 
10.27 
9.91 
10.21 
10.15 
99.9 
100.4 
102.7 
99.3 
102.3 
101.6 
99.9 
100.4 
102.7 
99.1 
102.1 
101.5 
 
1.504 
 
 
1.568 
 
1.500 
 
1.574 
15 
15 
15 
15 
15 
15 
14.78 
14.86 
15.14 
14.87 
14.99 
15.27 
14.76 
14.86 
15.14 
14.87 
14.99 
15.28 
98.4 
99.1 
100.9 
99.19 
99.9 
101.8 
98.4 
99.1 
100.9 
99.1 
99.9 
101.8 
 
1.326 
 
1.381 
 
1.324 
 
1.389 
20 
20 
20 
20 
20 
20 
20.26 
19.84 
19.88 
20.22 
19.94 
19.78 
20.26 
19.84 
19.88 
20.23 
19.94 
19.78 
101.3 
99.2 
99.4 
101.1 
99.7 
98.9 
101.3 
99.2 
99.4 
101.1 
99.7 
98.9 
 
1.145 
 
1.122 
 
1.144 
 
1.121 
Table VII: Precision results obtained using developed PCR and PLS models (Interday Precision) 
Amount Taken 
μg/ml 
Predicted Conc. μg/ml % Recovery % RSD 
 
ATV 
 
EZT 
PCR 
ATV          EZT 
PLS 
ATV          EZT 
PCR 
ATV          EZT 
PLS 
ATV          EZT 
PCR 
ATV          EZT 
PLS 
ATV          EZT 
10 
10 
10 
10 
10 
10 
10.01 
10.29 
10.30 
10.04 
10.25 
10.26 
10.00 
10.28 
10.29 
10.03 
10.25 
10.26 
100.1 
102.9 
103.0 
100.4 
102.5 
102.6 
100.0 
102.8 
102.9 
100.3 
102.5 
102.6 
 
1.614 
 
1.245 
 
1.616 
 
1.242 
15 
15 
15 
15 
15 
15 
15.58 
15.91 
15.87 
15.33 
15.58 
15.55 
15.57 
15.90 
15.86 
15.32 
15.57 
15.54 
103.9 
106.0 
105.8 
102.2 
103.8 
103.6 
103.8 
106.0 
105.7 
102.1 
103.8 
103.6 
 
1.123 
 
0.881 
 
 
1.124 
 
0.881 
20 
20 
20 
20 
20 
20 
21.22 
21.36 
21.33 
20.66 
20.77 
20.75 
21.21 
21.35 
21.32 
20.65 
20.76 
20.74 
106.1 
106.8 
106.6 
103.3 
103.8 
103.7 
106.0 
106.7 
106.6 
103.2 
103.8 
103.7 
 
0.355 
 
0.281 
 
0.355 
 
0.281 
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RESULTS AND DISCUSSION 
Out of 36 mixtures, 28 set of mixtures were used for calibration 
and 08 set of mixtures were used for validation. The models 
were tried to develop with varying  λ. The best results were 
obtained with the wavelengths intervals λ= 0.5 nm in methanol. 
The developed method found to be accurate as results are close 
to 100 % and precise with % RSD less than 2. Summary of 
results is presented in Table VIII. The limitations of the 
reported method [16] found to narrower range (8-14 μg/ml), 
less accuracy (94.1 - 108.9 %) and large scanning range (210-
300 nm) as compare our developed methods. 
 
CONCLUSION 
A study of the use of UV spectrophotometric in combination 
with PLS and PCR for the simultaneous determination of 
Atorvastatin calcium (ATV) and Ezetimibe (EZT) in a binary 
mixture has been accomplished. The results obtained confirmed 
the suitability of the proposed method for simple, accurate and 
precise analysis of ATV and EZT in pharmaceutical 
preparations. The proposed methods do not need separation of 
ATV and EZT before analysis. In addition, the proposed 
methods can be applied for analysis of drugs in quality control 
lab as well as for in process quality control. 
Table VIII: Summary of results 
Parameters Atorvastatin 
calcium (ATV) 
Ezetimibe (EZT) 
 PCR PLS PCR PLS 
Range (μg/ml) 5.0-30.0 5.0-30.0 5.0-30.0 5.0-30.0 
Wavelength, nm 230- 260 230- 260 230- 260 230- 260 
Data interval , ∆λ 0.5 0.5 0.5 0.5 
Factors/ PC’s 2 2 2 2 
% Recovery 99.3 99.3 99.5 99.6 
LOD 0.53 0.53 0.18 0.18 
LOQ 1.61 1.61 0.57 0.57 
Correlation 
Coefficient (r2) 
0.9968 0.9968 0.9922 0.9922 
Intercept 0.0564 0.0563 0.1415 0.1415 
Slope 0.9968 0.9968 0.9922 0.9922 
RMSECV 0.42649 0.48623 0.7097 0.7089 
RMSEP 0.4864 0.4862 0.7089 0.7089 
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